Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.

Ray P, Kar A, Fushimi K, Havlioglu N, Chen X, Wu JY.

J Mol Neurosci. 2011 Nov;45(3):453-66. doi: 10.1007/s12031-011-9634-z. Epub 2011 Sep 1.

2.

Small nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic stress.

Michel CI, Holley CL, Scruggs BS, Sidhu R, Brookheart RT, Listenberger LL, Behlke MA, Ory DS, Schaffer JE.

Cell Metab. 2011 Jul 6;14(1):33-44. doi: 10.1016/j.cmet.2011.04.009.

3.

Consensus PP1 binding motifs regulate transcriptional corepression and alternative RNA splicing activities of the steroid receptor coregulators, p54nrb and PSF.

Liu L, Xie N, Rennie P, Challis JR, Gleave M, Lye SJ, Dong X.

Mol Endocrinol. 2011 Jul;25(7):1197-210. doi: 10.1210/me.2010-0517. Epub 2011 May 12.

PMID:
21566083
4.

C16-Ceramide Analog Combined with Pc 4 Photodynamic Therapy Evokes Enhanced Total Ceramide Accumulation, Promotion of DEVDase Activation in the Absence of Apoptosis, and Augmented Overall Cell Killing.

Separovic D, Saad ZH, Edwin EA, Bielawski J, Pierce JS, Buren EV, Bielawska A.

J Lipids. 2011;2011:713867. doi: 10.1155/2011/713867. Epub 2010 Dec 14.

5.

Molecular basis of purine-rich RNA recognition by the human SR-like protein Tra2-β1.

Cléry A, Jayne S, Benderska N, Dominguez C, Stamm S, Allain FH.

Nat Struct Mol Biol. 2011 Apr;18(4):443-50. doi: 10.1038/nsmb.2001. Epub 2011 Mar 13.

PMID:
21399644
6.

Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response.

Separovic D, Bielawski J, Pierce JS, Merchant S, Tarca AL, Bhatti G, Ogretmen B, Korbelik M.

Int J Oncol. 2011 Feb;38(2):521-7. doi: 10.3892/ijo.2010.863. Epub 2010 Dec 6.

7.

The SR protein family.

Shepard PJ, Hertel KJ.

Genome Biol. 2009;10(10):242. doi: 10.1186/gb-2009-10-10-242. Epub 2009 Oct 27. Review.

8.

RISC hitches onto endosome trafficking.

Siomi H, Siomi MC.

Nat Cell Biol. 2009 Sep;11(9):1049-51. doi: 10.1038/ncb0909-1049.

PMID:
19724258
9.

Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity.

Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O.

Nat Cell Biol. 2009 Sep;11(9):1143-9. doi: 10.1038/ncb1929. Epub 2009 Aug 16. Erratum in: Nat Cell Biol. 2009 Oct;11(10):1272.

PMID:
19684575
10.

Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis.

Pamuklar Z, Federico L, Liu S, Umezu-Goto M, Dong A, Panchatcharam M, Fulkerson Z, Berdyshev E, Natarajan V, Fang X, van Meeteren LA, Moolenaar WH, Mills GB, Morris AJ, Smyth SS.

J Biol Chem. 2009 Mar 13;284(11):7385-94. doi: 10.1074/jbc.M807820200. Epub 2009 Jan 12. Erratum in: J Biol Chem. 2009 Jul 31;284(31):21100. Fulerson, Zachary [corrected to Fulkerson, Zachary].

11.

Identification of alternative splicing markers for breast cancer.

Venables JP, Klinck R, Bramard A, Inkel L, Dufresne-Martin G, Koh C, Gervais-Bird J, Lapointe E, Froehlich U, Durand M, Gendron D, Brosseau JP, Thibault P, Lucier JF, Tremblay K, Prinos P, Wellinger RJ, Chabot B, Rancourt C, Elela SA.

Cancer Res. 2008 Nov 15;68(22):9525-31. doi: 10.1158/0008-5472.CAN-08-1769.

12.

Alternative splicing and disease.

Tazi J, Bakkour N, Stamm S.

Biochim Biophys Acta. 2009 Jan;1792(1):14-26. doi: 10.1016/j.bbadis.2008.09.017. Epub 2008 Oct 17. Review.

13.

Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing.

Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ.

Nat Genet. 2008 Dec;40(12):1413-5. doi: 10.1038/ng.259. Epub 2008 Nov 2. Erratum in: Nat Genet. 2009 Jun;41(6):762.

PMID:
18978789
14.

Rapid generation of splicing reporters with pSpliceExpress.

Kishore S, Khanna A, Stamm S.

Gene. 2008 Dec 31;427(1-2):104-10. doi: 10.1016/j.gene.2008.09.021. Epub 2008 Oct 1.

15.

Nuclear inhibitor of protein phosphatase-1 (NIPP1) directs protein phosphatase-1 (PP1) to dephosphorylate the U2 small nuclear ribonucleoprotein particle (snRNP) component, spliceosome-associated protein 155 (Sap155).

Tanuma N, Kim SE, Beullens M, Tsubaki Y, Mitsuhashi S, Nomura M, Kawamura T, Isono K, Koseki H, Sato M, Bollen M, Kikuchi K, Shima H.

J Biol Chem. 2008 Dec 19;283(51):35805-14. doi: 10.1074/jbc.M805468200. Epub 2008 Oct 8.

16.

Nuclear sphingolipids: metabolism and signaling.

Ledeen RW, Wu G.

J Lipid Res. 2008 Jun;49(6):1176-86. doi: 10.1194/jlr.R800009-JLR200. Epub 2008 Mar 9. Review.

17.

Lipid signalling in disease.

Wymann MP, Schneiter R.

Nat Rev Mol Cell Biol. 2008 Feb;9(2):162-76. doi: 10.1038/nrm2335. Review.

PMID:
18216772
18.

Regulation of alternative splicing by reversible protein phosphorylation.

Stamm S.

J Biol Chem. 2008 Jan 18;283(3):1223-7. Epub 2007 Nov 16. Review.

19.

Structure-specific, quantitative methods for analysis of sphingolipids by liquid chromatography-tandem mass spectrometry: "inside-out" sphingolipidomics.

Sullards MC, Allegood JC, Kelly S, Wang E, Haynes CA, Park H, Chen Y, Merrill AH Jr.

Methods Enzymol. 2007;432:83-115.

PMID:
17954214
20.

Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing.

Novoyatleva T, Heinrich B, Tang Y, Benderska N, Butchbach ME, Lorson CL, Lorson MA, Ben-Dov C, Fehlbaum P, Bracco L, Burghes AH, Bollen M, Stamm S.

Hum Mol Genet. 2008 Jan 1;17(1):52-70. Epub 2007 Oct 2.

PMID:
17913700

Supplemental Content

Support Center